Interpace Diagnostics Group Inc (NASDAQ:IDXG) released its quarterly earnings results on Wednesday. The business services provider reported ($0.04) earnings per share for the quarter. The firm had revenue of $3.12 million for the quarter. Interpace Diagnostics Group had a negative return on equity of 353.81% and a negative net margin of 81.73%.
Interpace Diagnostics Group (NASDAQ:IDXG) traded down 9.62% during mid-day trading on Friday, reaching $2.35. The company had a trading volume of 1,550,155 shares. The stock’s market capitalization is $15.80 million. The company’s 50-day moving average is $2.45 and its 200-day moving average is $2.06. Interpace Diagnostics Group has a one year low of $0.07 and a one year high of $14.25.
TRADEMARK VIOLATION WARNING: This story was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://transcriptdaily.com/2017/04/22/interpace-diagnostics-group-inc-idxg-announces-quarterly-earnings-results.html.
Interpace Diagnostics Group, Inc, formerly PDI, Inc, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management.
